Safety and efficacy of mFOLFOX6+panitumumab combination therapy and 5-FU/LV + panitumumab combination therapy in patients with chemotherapy-naive metastatic colorectal cancer (SAPPHIRE)

被引：0
|
作者：
Nagata, N. [1 ]
Mishima, H. [2 ]
Kurosawa, S. [3 ]
Oba, K. [4 ]
Sakamoto, J. [5 ]
机构：
[1] Kitakyushu Gen Hosp, Surg, Kitakyushu, Fukuoka, Japan
[2] Aichi Med Univ, Clin Oncol, Nagakute, Aichi 48011, Japan
[3] Takeda Pharmaceut Co Ltd, GMA J, Tokyo, Japan
[4] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Biostat, Tokyo, Japan
[5] Tokai Cent Hosp, Kakamigahara, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
228TiP
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212).
    Modest, Dominik Paul
    Karthaus, Meinolf
    Fruehauf, Stefan
    Graeven, Ullrich
    Mueller, Lothar
    Koenig, Alexander
    Von Weikersthal, Ludwig Fischer
    Caca, Karel
    Kretzschmar, Albrecht
    Goekkurt, Eray
    Haas, Siegfried
    Kurreck, Annika
    Stahler, Arndt
    Heinemann, Volker
    Held, Swantje
    Jarosch, Armin
    Horst, David
    Kasper, Stefan
    Stintzing, Sebastian
    Trarbach, Tanja
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in previously treated patients with advanced metastatic gastric cancer
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Anselmi, E
    Bidin, L
    Palladino, M
    Rodinò, C
    ANNALS OF ONCOLOGY, 2005, 16 : 323 - 323
  • [43] Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    da Silva, Wania Cristina
    de Araujo, Vania Eloisa
    Lima, Ellias Magalhaes e Abreu
    Ribeiro dos Santos, Jessica Barreto
    Ribeiro da Silva, Michael Ruberson
    Ribeiro Fernandes Almeida, Paulo Henrique
    Acurcio, Francisco de Assis
    Godman, Brian
    Kurdi, Amanj
    Cherchiglia, Mariangela Leal
    Gurgel Andrade, Eli Iola
    BIODRUGS, 2018, 32 (06) : 585 - 606
  • [44] Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    Wânia Cristina da Silva
    Vânia Eloisa de Araujo
    Ellias Magalhães e Abreu Lima
    Jessica Barreto Ribeiro dos Santos
    Michael Ruberson Ribeiro da Silva
    Paulo Henrique Ribeiro Fernandes Almeida
    Francisco de Assis Acurcio
    Brian Godman
    Amanj Kurdi
    Mariângela Leal Cherchiglia
    Eli Iola Gurgel Andrade
    BioDrugs, 2018, 32 : 585 - 606
  • [45] A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer
    Fakih, M. G.
    Groman, A.
    McMahon, J.
    Wilding, G.
    Muindi, J. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 743 - 751
  • [46] A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer
    M. G. Fakih
    A. Groman
    J. McMahon
    G. Wilding
    J. R. Muindi
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 743 - 751
  • [47] The Impact of Omitting 5-FU Bolus From mFOLFOX6 Chemotherapy Regimen on Hematological Adverse Events Among Patients With Metastatic Colorectal Cancer
    Areepium, Nutthada
    Sapapsap, Bannawich
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (05) : 392 - 400
  • [48] Efficacy and safety of addition of bevacizumab to FOLFIRI or irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer A meta-analysis
    Chen, Ke
    Gong, Yinya
    Zhang, Qi
    Shen, Yanping
    Zhou, Taoqi
    MEDICINE, 2016, 95 (46)
  • [49] Efficacy and safety of regorafenib in combination with chemotherapy as second-line therapy in patients with metastatic colorectal cancer: A network meta-analysis
    Xie, Xiaoyu
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Wu, Zehua
    Ling, Jiayu
    Li, Weiwei
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [50] Phase I trial of ZD1839 ('Iressa') in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer.
    de Bono, JS
    Hammond, LA
    Figueroa, J
    Schwartzberg, L
    Ochoa, L
    Patnaik, A
    Olivo, N
    Schwartz, G
    Smith, L
    Ochs, J
    Rowinsky, EK
    BRITISH JOURNAL OF CANCER, 2002, 86 : S50 - S51
12345